Pulse-invigorating capsule for treating carotid artery atherosclerosis as well as preventing and treating ischemic cerebral apoplexy

Abstract

The invention provides a pulse-invigorating capsule for treating carotid artery atherosclerosis as well as preventing and treating ischemic cerebral apoplexy, which is composed of red sage root, coptis, root of kudzu vine and pseudo-ginseng with weight percentage of 50-55%: 15-20%: 15-20%: 5-10%. The pulse-invigorating capsule for treating carotid artery atherosclerosis as well as preventing and treating ischemic cerebral apoplexy has the characteristics of multiple targets and multiple approaches, and has integration and regulation effects with multiple targets on atherosclerotic plaque. The pulse-invigorating capsule can inhibit the formation of neointima through antithrombosis, anti inflammatory, endothelial cells injury restoration, lipid lowering, microcirculation improvement, blood vessel smooth muscle cell propagation inhibition and the like, the antiatherosclerosis effect can be performed, and the pulse-invigorating capsule can promote the restoration of tissue of the operation blood vessel wound, can prevent several phases of a restenosis process at an early stage after a CEA operation, and the several phases comprise a thrombus formation phase, an inflammation reaction phase, an endothelial restoration phase, a blood vessel smooth muscle propagation phase, a matrix formation phase and the like.

Description

technical field [0001] The invention relates to a traditional Chinese medicine for treating carotid atherosclerosis and preventing and treating iron-deficiency cerebral apoplexy, which is a Tongmai capsule for treating carotid atherosclerosis and preventing and preventing ischemic cerebral apoplexy. Background technique [0002] Stroke is a common and frequently-occurring disease that endangers human life and health. It has the characteristics of high morbidity, high mortality, high disability rate, and high recurrence rate. It ranks the third cause of human death and the first cause of disability. . In my country, there are about 2 million new patients every year, more than 1.5 million deaths, about 75% of the survivors are disabled, and the recurrence rate within 5 years is as high as 41%. The existing patients in the country are 6-7 million. Among them, hemorrhagic disease accounted for 29.3%, ischemic disease accounted for 62.4%, unknown accounted for 8.3%, and the annu...

AI Technical Summary

Problems solved by technology

Since the problem of restenosis affects the long-term efficacy and is the final result of a series of complicated related events, the pathological mechanism is not very clear, and the currently used aspirin and statin lipid-lowering drugs are not satisfactory to try to change or control this process

Images